Skip to main content
. 2022 Apr 13;13:758524. doi: 10.3389/fphar.2022.758524

FIGURE 3.

FIGURE 3

Tacrolimus CL/F in CD children undergoing HSCT. a: without posaconazole. b: with posaconazole. ** p < 0.01 vs. children without posaconazole (measured tacrolimus concentrations).